These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
151 related articles for article (PubMed ID: 6240662)
21. The emerging role of clozapine in the treatment of movement disorders. Factor SA; Friedman JH Mov Disord; 1997 Jul; 12(4):483-96. PubMed ID: 9251065 [TBL] [Abstract][Full Text] [Related]
22. Treatment of migraine and cluster headache. Peatfield RC; Rose FC Practitioner; 1981 Sep; 225(1359):1321-5. PubMed ID: 7312791 [No Abstract] [Full Text] [Related]
23. [Current therapeutic possibilities in neurology]. Uldry PA Rev Med Suisse Romande; 1992 Jul; 112(7):629-34. PubMed ID: 1496214 [No Abstract] [Full Text] [Related]
24. Treatment of migraine and cluster headache. Rose FC; Peatfield RC Panminerva Med; 1982; 24(2):85-7. PubMed ID: 7145460 [No Abstract] [Full Text] [Related]
25. Therapeutics of disordered movement. Sears ES Am Fam Physician; 1977 Sep; 16(3):145-54. PubMed ID: 143204 [TBL] [Abstract][Full Text] [Related]
26. Effect of lithium on neuroleptic-induced tardive dyskinesia compared with placebo in a double-blind cross-over trial. Gerlach J; Thorsen K; Munkvad I Pharmakopsychiatr Neuropsychopharmakol; 1975 Mar; 8(2):51-6. PubMed ID: 788002 [TBL] [Abstract][Full Text] [Related]
27. Parkinson's disease, Huntington's disease and tardive dyskinesia. Neurochemical pathology and treatment. Tolosa ES Minn Med; 1979 Feb; 62(2):101-6. PubMed ID: 155195 [No Abstract] [Full Text] [Related]
33. How to treat migraine. Peatfield R Br J Hosp Med; 1984 Feb; 31(2):142-4. PubMed ID: 6697051 [No Abstract] [Full Text] [Related]
34. Lithium treatment of Huntington's chorea. A placebo-controlled clinical trial. Vestergaard P; Baastrup PC; Petersson H Acta Psychiatr Scand; 1977 Sep; 56(3):183-8. PubMed ID: 143188 [TBL] [Abstract][Full Text] [Related]
35. [Clinical study on the treatment of dyskinesia by L-stepholidine]. Le W Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1989 Dec; 22(6):335-7, 381-2. PubMed ID: 2700694 [TBL] [Abstract][Full Text] [Related]
36. L-tryptophan in neuropsychiatric disorders: a review. Sandyk R Int J Neurosci; 1992; 67(1-4):127-44. PubMed ID: 1305630 [TBL] [Abstract][Full Text] [Related]
38. Psychiatric aspects of abnormal movement disorders. Flinn D; Bazzell W Brain Res Bull; 1983 Aug; 11(2):153-61. PubMed ID: 6138131 [TBL] [Abstract][Full Text] [Related]
39. Tetrabenazine, a monoamine-depleting drug used in the treatment of hyperkinetic movement disorders. Guay DR Am J Geriatr Pharmacother; 2010 Aug; 8(4):331-73. PubMed ID: 20869622 [TBL] [Abstract][Full Text] [Related]